Skoči na glavni sadržaj

ADMET and DMPK , Vol. 4 No. 3, 2016.

  • Datum izdavanja: 30.09.2016.
  • Objavljen na Hrčku: 01.10.2016.

Sadržaj

Puni tekst

Tyrosine kinase inhibitors for EGFR- and ALK-mutated non-small cell lung cancer (str. 186-211)

Jonathan R. Thompson, Smitha P. Menon, Grace K. Dy
Pregledni rad


Cross talk of c-Jun N-terminal kinase and p38 map kinase modulate insulin and TNFα-stimulated VCAM-1 expression in rat aorta endothelial cells (str. 232-240)

Gregory B. Pott, Mark Tsurudome, Jamie Bui, Chelsea Gardner, Marc Goalstone
Izvorni znanstveni članak


Dose optimization of ceftriaxone-vancomycin combination using fractional inhibitory concentration kinetics in resistant bacteria (str. 241-260)

Vishnu D Sharma, Aman Singla, Manu Chaudhary, Mukesh Kumar, Anuj Bhatnagar, Shailesh Kumar, Manish Taneja
Izvorni znanstveni članak


Evaluation of P-glycoprotein expression in pain relevant tissues: understanding translation of efflux from preclinical species to human (str. 261-268)

Renu Singh Dhanikula, Cyrla Hoffert, Rebecca Grant, Denis Projean, Rosemarie Panetta, Dajan O’Donnell, Marie Roumi
Izvorni znanstveni članak


Posjeta: 13.657 *